Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders

Daily Updates


Shares of Agios Pharmaceuticals  (AGIO) – Get Report jumped Monday after the drugmaker agreed to sell its oncology portfolio to French pharmaceutical firm Servier for up to $2 billion.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *